Sunesis Pharmaceuticals Overview

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) is a leading discovery-based pharmaceutical company that applies its breakthrough fragment-based technologies to create superior oral therapeutics for the most challenging and important disease targets. Sunesis is building a pipeline of innovative therapeutics addressing major diseases through internal development and selective partnering. TetheringSM,...More»

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) is a leading discovery-based pharmaceutical company that applies its breakthrough fragment-based technologies to create superior oral therapeutics for the most challenging and important disease targets. Sunesis is building a pipeline of innovative therapeutics addressing major diseases through internal development and selective partnering. TetheringSM, Sunesis' fragment-based drug discovery, reliably generates small-molecule leads against challenging enzyme targets and protein-protein interfaces by screening greater diversity space and identifying binding ligands that other techniques, such as high throughput screening, are too insensitive to find. In conjunction with TetheringSM, Sunesis advances its portfolio through the expert application of x-ray crystallography, computational modeling and medicinal chemistry.«Less